U.S. Markets close in 2 hrs 41 mins
  • S&P 500

    4,303.42
    -94.52 (-2.15%)
     
  • Dow 30

    33,626.83
    -638.54 (-1.86%)
     
  • Nasdaq

    13,455.42
    -313.50 (-2.28%)
     
  • Russell 2000

    1,987.92
    -36.12 (-1.78%)
     
  • Crude Oil

    0 (0)
     
  • Gold

    1,836.10
    -6.50 (-0.35%)
     
  • Silver

    24.34
    -0.37 (-1.50%)
     
  • EUR/USD

    1.1348
    +0.0031 (+0.2724%)
     
  • 10-Yr Bond

    1.7190
    -0.0280 (-1.60%)
     
  • Vix

    28.85
    +3.26 (+12.74%)
     
  • GBP/USD

    1.3555
    -0.0045 (-0.3321%)
     
  • USD/JPY

    113.6500
    -0.4500 (-0.3944%)
     
  • BTC-USD

    35,869.24
    +571.04 (+1.62%)
     
  • CMC Crypto 200

    815.72
    +5.12 (+0.63%)
     
  • FTSE 100

    7,494.13
    -90.88 (-1.20%)
     
  • Nikkei 225

    27,522.26
    -250.64 (-0.90%)
     

The Independent Director of Applied Molecular Transport Inc. (NASDAQ:AMTI), David Lamond, Just Bought 2.5% More Shares

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • AMTI

Applied Molecular Transport Inc. (NASDAQ:AMTI) shareholders (or potential shareholders) will be happy to see that the Independent Director, David Lamond, recently bought a whopping US$1.1m worth of stock, at a price of US$42.00. There's no denying a buy of that magnitude suggests conviction in a brighter future, although we do note that proportionally it only increased their holding by 2.5%.

See our latest analysis for Applied Molecular Transport

The Last 12 Months Of Insider Transactions At Applied Molecular Transport

Over the last year, we can see that the biggest insider purchase was by insider Chad Boeding for US$3.1m worth of shares, at about US$14.00 per share. We do like to see buying, but this purchase was made at well below the current price of US$55.70. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

In the last twelve months Applied Molecular Transport insiders were buying shares, but not selling. The average buy price was around US$16.86. It is certainly positive to see that insiders have invested their own money in the company. However, we do note that they were buying at significantly lower prices than today's share price. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

Applied Molecular Transport is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership of Applied Molecular Transport

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Applied Molecular Transport insiders own 27% of the company, currently worth about US$579m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

So What Does This Data Suggest About Applied Molecular Transport Insiders?

It is good to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. When combined with notable insider ownership, these factors suggest Applied Molecular Transport insiders are well aligned, and quite possibly think the share price is too low. One for the watchlist, at least! While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 3 warning signs for Applied Molecular Transport (1 is concerning!) that we believe deserve your full attention.

Of course Applied Molecular Transport may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.